Journal article icon

Journal article

Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor

Abstract:
A potent inhibitor of the JmjC histone lysine demethylase KDM2A (compound 35, pIC50 7.2) with excellent selectivity over representatives from other KDM subfamilies has been developed; the discovery that a triazolopyridine compound binds to the active site of JmjC KDMs was followed by optimisation of the triazole substituent for KDM2A inhibition and selectivity. This journal is
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1039/c4md00291a

Authors


Publisher:
Royal Society of Chemistry
Journal:
MEDCHEMCOMM More from this journal
Volume:
5
Issue:
12
Pages:
1879-1886
Publication date:
2014-01-01
DOI:
EISSN:
2040-2511
ISSN:
2040-2503


Language:
English
Pubs id:
pubs:492501
UUID:
uuid:c8e6bc5c-c1a6-4979-89ab-3e329b8a4b44
Local pid:
pubs:492501
Source identifiers:
492501
Deposit date:
2014-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP